These findings indicated that CBX4 served as a potential oncogene in prostate cancer, the down-regulation of CBX4 significantly inhibited the proliferation, invasion and migration of prostate cancer cells, which might act through the PI3K/AKT signaling pathway. The gene discussed is CBX4; the disease is prostate carcinoma.